Tecovirimat Well Tolerated for Treatment of Monkeypox

FRIDAY, Aug. 26, 2022 -- Compassionate use of tecovirimat is well tolerated for the treatment of monkeypox, according to a research letter published online Aug. 22 in the Journal of the American Medical Association. Angel N. Desai, M.D., M.P.H.,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news